{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:13:38Z","timestamp":1791414818105,"version":"4.3.3"},"reference-count":85,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jsbmb.2007.09.020","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T08:21:44Z","timestamp":1190017304000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Novel molecular profiles of endometrial cancer\u2014new light through old windows"],"prefix":"10.1016","volume":"108","author":[{"given":"A.","family":"Doll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Demajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Col\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Llaurad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Alazzouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Planagum\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Castellvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ramon y","family":"Cajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gil-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Xercavins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Alameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Revent\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2007.09.020_bib1","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses","volume":"81","author":"Lax","year":"1997","journal-title":"Verh. Dtsch. Ges. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0046-8177(98)90197-6","article-title":"Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation","volume":"29","author":"Lax","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib3","first-page":"963","article-title":"Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas","volume":"10","author":"Sherman","year":"1997","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib4","first-page":"27","article-title":"Molecular genetics and endometrial cancer","volume":"9","author":"Oehler","year":"2003","journal-title":"J. Br. Menopause Soc."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib5","first-page":"3607","article-title":"Methylation of hMLH1 in a population-based series of endometrial carcinomas","volume":"6","author":"Salvesen","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0046-8177(98)90430-0","article-title":"Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases","volume":"29","author":"Catasus","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib7","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/01.MP.0000095646.70007.6A","article-title":"Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability","volume":"16","author":"Hardisson","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib9","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/cncr.10498","article-title":"Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis","volume":"94","author":"Koul","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S","article-title":"PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma","volume":"91","author":"Salvesen","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib11","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1158\/0008-5472.CAN-06-0248","article-title":"MLH3 mutation in endometrial cancer","volume":"66","author":"Taylor","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/ijgc-00009577-200605000-00072","article-title":"MSH2 splice site mutation and endometrial cancer","volume":"16","author":"Bianchi","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib13","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/sj.onc.1202178","article-title":"MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas","volume":"17","author":"Esteller","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib14","first-page":"957","article-title":"Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series","volume":"14","author":"Macdonald","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.2003.tb05975.x","article-title":"Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers","volume":"983","author":"Risinger","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib16","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0959-8049(97)00154-8","article-title":"The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer","volume":"33","author":"Esteller","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH769>3.0.CO;2-9","article-title":"K-ras mutations in endometrial carcinomas with microsatellite instability","volume":"193","author":"Lagarda","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib19","first-page":"1906","article-title":"Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma","volume":"53","author":"Sasaki","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib20","first-page":"1241","article-title":"Involvement of the ras genes in female genital tract cancer","volume":"26","author":"Mammas","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib21","first-page":"197","article-title":"Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors","volume":"21","author":"Abal","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib22","first-page":"2109","article-title":"The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies","volume":"9","author":"Dougall","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000011931","article-title":"Mutations and amplification of oncogenes in endometrial cancer","volume":"56","author":"Niederacher","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib24","first-page":"5693","article-title":"Amplification and overexpression of HER-2\/neu (c-erbB2) in endometrial cancers: correlation with overall survival","volume":"55","author":"Saffari","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exmp.1999.2289","article-title":"Fluorescence in situ hybridization analysis of HER-2\/neu, c-myc, and p53 in endometrial cancer","volume":"67","author":"Williams","year":"1999","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ijgc-00009577-200401000-00018","article-title":"Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival","volume":"14","author":"Geisler","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib27","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1038\/sj.onc.1205463","article-title":"Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells","volume":"21","author":"Wang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/1568009043332871","article-title":"The relationship between oncogene expression and clinical outcome in endometrial carcinoma","volume":"4","author":"Takai","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/geno.1996.0345","article-title":"Genomic organization of the human ERM (ETV5) gene, a PEA3 group member of ETS transcription factors","volume":"35","author":"Monte","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature03894","article-title":"ERM is required for transcriptional control of the spermatogonial stem cell niche","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib31","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1158\/0008-5472.CAN-04-2066","article-title":"A differential gene expression profile reveals overexpression of RUNX1\/AML1 in invasive endometrioid carcinoma","volume":"64","author":"Planaguma","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/path.1853","article-title":"Up-regulation of ERM\/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma","volume":"207","author":"Planaguma","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrc1607","article-title":"The RUNX genes: gain or loss of function in cancer","volume":"5","author":"Blyth","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.humpath.2006.03.007","article-title":"The up-regulation profiles of p21WAF1\/CIP1 and RUNX1\/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma","volume":"37","author":"Planaguma","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.semcdb.2004.01.002","article-title":"PI 3-kinase, Akt and cell survival","volume":"15","author":"Downward","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0163-7258(02)00193-6","article-title":"Inhibition of protein kinase B\/Akt. implications for cancer therapy","volume":"93","author":"Hill","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(03)00021-7","article-title":"PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms","volume":"3","author":"Freeman","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/gyno.1998.5208","article-title":"PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors","volume":"71","author":"Simpkins","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ijc.21862","article-title":"The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer","volume":"119","author":"Bilbao","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib42","first-page":"3254","article-title":"PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma","volume":"58","author":"Levine","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib43","first-page":"2500","article-title":"Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias","volume":"58","author":"Maxwell","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00001703-200202000-00010","article-title":"PTEN mutations and evolving concepts in endometrial neoplasia","volume":"14","author":"Latta","year":"2002","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib45","first-page":"1615","article-title":"Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression","volume":"25","author":"Salvesen","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"Pt 1","key":"10.1016\/j.jsbmb.2007.09.020_bib46","first-page":"123","article-title":"The E-cadherin\/catenin complex in invasion and metastasis","volume":"213","author":"Bracke","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib47","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/j.1460-2075.1989.tb03563.x","article-title":"The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species","volume":"8","author":"Ozawa","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001622-199801000-00013","article-title":"The role of beta-catenin in cell adhesion, signal transduction, and cancer","volume":"10","author":"Bullions","year":"1998","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib49","first-page":"3526","article-title":"Beta-catenin mutation in carcinoma of the uterine endometrium","volume":"58","author":"Fukuchi","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib50","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1205924","article-title":"Abnormalities of the APC\/beta-catenin pathway in endometrial cancer","volume":"21","author":"Moreno-Bueno","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/01.MP.0000028573.34289.04","article-title":"Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype","volume":"15","author":"Schlosshauer","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s004280000371","article-title":"Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability","volume":"438","author":"Palacios","year":"2001","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjoc.2000.1581","article-title":"beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis","volume":"84","author":"Saegusa","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/path.856","article-title":"Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation","volume":"194","author":"Saegusa","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1098-2744(199901)24:1<15::AID-MC3>3.0.CO;2-Y","article-title":"Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress","volume":"24","author":"Yin","year":"1999","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0046-8177(96)90340-8","article-title":"Uterine papillary serous carcinoma evolves via a p53-driven pathway","volume":"27","author":"Moll","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/gyno.1996.0120","article-title":"p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes","volume":"61","author":"Zheng","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib58","first-page":"1379","article-title":"Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells","volume":"86","author":"Lecce","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib59","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1073\/pnas.97.11.5936","article-title":"Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus","volume":"97","author":"Weihua","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib60","first-page":"97","article-title":"BCL-2 and P53 expression in endometrial carcinoma","volume":"23","author":"Erkanli","year":"2004","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib61","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib62","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/0929867003374958","article-title":"Steroids and the endometrium","volume":"7","author":"Oehler","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib63","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1038\/sj.onc.1204809","article-title":"Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression","volume":"20","author":"Jazaeri","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1349-7006.2000.tb00975.x","article-title":"Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium","volume":"91","author":"Saegusa","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1525-1438.2000.00009.x","article-title":"Exon deletions and variants of human estrogen receptor mRNA in endometrial hyperplasia and adenocarcinoma","volume":"10","author":"Horvath","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib66","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/en.2004-0825","article-title":"The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells","volume":"146","author":"Bryant","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/er.2003-0010","article-title":"Estrogen receptor mutations in human disease","volume":"25","author":"Herynk","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib68","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1210\/mend.15.12.0739","article-title":"Differential role of PR-A and -B isoforms in transcription regulation of human GnRH receptor gene","volume":"15","author":"Cheng","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib69","first-page":"4576","article-title":"Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium","volume":"61","author":"Arnett-Mansfield","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib70","doi-asserted-by":"crossref","first-page":"12263","DOI":"10.1073\/pnas.192172299","article-title":"A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk","volume":"99","author":"De Vivo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib72","first-page":"1377","article-title":"Advances in the molecular genetics of endometrial cancer (Review)","volume":"6","author":"Esteller","year":"1999","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib73","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ajcp\/111.3.336","article-title":"Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation","volume":"111","author":"Esteller","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification","volume":"444","author":"Lax","year":"2004","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib75","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1016\/S0021-9258(17)42922-X","article-title":"Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells","volume":"259","author":"Schneider","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib76","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/bjc.1997.235","article-title":"Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci","volume":"75","author":"Esteller","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib77","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/carcin\/18.12.2307","article-title":"Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility","volume":"18","author":"Esteller","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib78","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/(SICI)1096-9896(200003)190:4<462::AID-PATH590>3.0.CO;2-D","article-title":"Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry","volume":"190","author":"Mutter","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib79","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00019606-200212000-00003","article-title":"Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia","volume":"11","author":"Sun","year":"2002","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib80","first-page":"109","article-title":"Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart","volume":"76","author":"Esteller","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib81","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1038\/sj.onc.1206365","article-title":"Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers","volume":"22","author":"Kanaya","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2007.09.020_bib82","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0002-9440(10)65492-2","article-title":"hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis","volume":"155","author":"Esteller","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib83","first-page":"1604","article-title":"Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma","volume":"54","author":"Duggan","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib84","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00004347-199904000-00007","article-title":"HER-2\/neu amplification and overexpression in endometrial carcinoma","volume":"18","author":"Rolitsky","year":"1999","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.jsbmb.2007.09.020_bib85","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/hupa.2001.25929","article-title":"Molecular pathology of endometrial hyperplasia and carcinoma","volume":"32","author":"Matias-Guiu","year":"2001","journal-title":"Hum. Pathol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076007002543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076007002543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:58:41Z","timestamp":1760734721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076007002543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":85,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0960076007002543"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2007.09.020","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel molecular profiles of endometrial cancer\u2014new light through old windows","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2007.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}